🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06946277
Starting soon Phase 4

Assessing the Time-Course of Dexmedetomidine-Induced Analgesia Via EEG

NCT06946277 · tracked via the Priya Life Science China tracker
Sponsor
China International Neuroscience Institution
Phase
Phase 4
Started
2026-11-25
Last updated
2026-09-10

Condition(s) studied

Total Hip Arthroplasty (THA)Intrathecal AnesthesiaHip Osteoarthritis

Investigational drug(s) / intervention(s)

Preemptive Analgesia Of Dexmedetomidine

Preemptive Analgesia Of Dexmedetomidine: Preemptive Analgesia Of Dexmedetomidine 1.5 μg · kg-1·h-1 before operation

Study summary

Objective: To investigate the temporal dynamics of dexmedetomidine's analgesic effects in the brain using EEG.

Methods: Eligible patients scheduled for total hip arthroplasty under intrathecal anesthesia received a continuous infusion of DEX at 1.5 μg/(kg·h) for 15 minutes before neuraxial puncture, followed by an additional 15-minute infusion. The study was divided into three phases:

Phase 1: Non-dosing phase (Baseline). Phase 2: DEX preemptive analgesia phase (DEX infusion). Phase 3: DEX cessation phase (Post-infusion).

Outcomes:

Primary safety outcome: EEG spectral analysis at different phases. Secondary outcomes: NRS scores, postoperative nausea and vomiting (PONV), dizziness, agitation, and time to intestinal exhaust within 48 hours. Intraoperative hemodynamics were also monitored.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: Patients with hip osteoarthritis scheduled for total hip arthroplasty under intrathecal anesthesia; Age 18-70 years; American Society of Anesthesiologists (ASA) physical status classification I-III; Body mass index (BMI) 22-30 kg/m². Exclusion Criteria: Pre-existing peripheral or central nervous system disorders; Mental disorders; Cognitive impairment; Emergency surgery; or Hearing impairment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xuanwu hospital Beijing Beijing Municipality

More China International Neuroscience Institution trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06946277 on ClinicalTrials.gov ↗ ← All trials in China